4//SEC Filing
Grant Richard N. Jr. 4
Accession 0001062993-25-005271
CIK 0001036262other
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 5:37 PM ET
Size
12.6 KB
Accession
0001062993-25-005271
Insider Transaction Report
Form 4
INTEST CORPINTT
Grant Richard N. Jr.
DirectorPresident & CEO
Transactions
- Sale
Common Stock
2025-03-10$7.48/sh−2,688$20,106→ 162,241 total - Sale
Common Stock
2025-03-11$7.57/sh−1,184$8,963→ 161,057 total
Holdings
- 30,536
Employee Stock Option (right to buy)
Exercise: $11.33Exp: 2034-03-05→ Common Stock (30,536 underlying) - 16,988
Employee Stock Option (right to buy)
Exercise: $16.06Exp: 2033-03-07→ Common Stock (16,988 underlying) - 25,692
Employee Stock Option (right to buy)
Exercise: $9.76Exp: 2032-03-08→ Common Stock (25,692 underlying) - 112,000
Employee Stock Option (right to buy)
Exercise: $10.62Exp: 2031-03-09→ Common Stock (112,000 underlying)
Footnotes (7)
- [F1]Shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2023.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.35 to $7.52, inclusive. Mr. Grant undertakes to provide inTEST Corporation, any security holder of inTEST Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.49 to $7.60, inclusive. Mr. Grant undertakes to provide inTEST Corporation, any security holder of inTEST Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]This option vests in four equal annual installments commencing on March 6, 2025.
- [F5]This option vests in four equal annual installments commencing on March 8, 2024.
- [F6]This option vests in four equal annual installments commencing on March 9, 2023.
- [F7]This option is fully vested as of the date of this report.
Issuer
INTEST CORP
CIK 0001036262
Entity typeother
Related Parties
1- filerCIK 0001821315
Filing Metadata
- Form type
- 4
- Filed
- Mar 11, 8:00 PM ET
- Accepted
- Mar 12, 5:37 PM ET
- Size
- 12.6 KB